Manning & Napier Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Manning & Napier Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.06M	Buy	218,977 +3,250	+2%	+$57K	0.06%	173
2025 Q4	$3.37M	Sell	215,727 -10,711	-5%	-$153K	0.04%	175
2025 Q3	$3.32M	Sell	226,438 -18,803	-8%	-$279K	0.04%	184
2025 Q2	$3.79M	Sell	245,241 -52,282	-18%	-$773K	0.05%	197
2025 Q1	$4.42M	Sell	297,523 -6,894	-2%	-$96.6K	0.05%	173
2024 Q4	$4.03M	Sell	304,417 -13,524	-4%	-$186K	0.05%	178
2024 Q3	$4.52M	Buy	317,941 +1,251	+0.4%	+$17.7K	0.05%	194
2024 Q2	$4.1M	Buy	+316,690	New	+$4.19M	0.05%	202

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manning & Napier Advisors's TAK Position: Q1 2026 in Review

Manning & Napier Advisors increased its Takeda Pharmaceutical (TAK) stake by 1.5% in Q1 2026, buying an estimated $57K and bringing the position to 218,977 shares worth $4.06M. The position accounts for 0.06% of the portfolio, ranked #173.

Manning & Napier Advisors first reported a position in TAK in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.52M in Q3 2024. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Manning & Napier Advisors held 218,977 shares of Takeda Pharmaceutical worth $4.06M as of Q1 2026.
Manning & Napier Advisors bought 3,250 Takeda Pharmaceutical shares in Q1 2026, an estimated $57K.
Takeda Pharmaceutical made up 0.06% of Manning & Napier Advisors's portfolio in Q1 2026, its #173 holding.
Manning & Napier Advisors first reported a position in Takeda Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
Manning & Napier Advisors's Takeda Pharmaceutical position peaked at $4.52M in Q3 2024.
359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.